BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value: $10.24B (100.0% shares, 0.0% debt)

Holdings (7)

— DIVERSEY HLDGS LTD 41.3%

Value $4.233B Shares 236,350,134 Est. Cost $14.71 Unrealized —

SGRY SURGERY PARTNERS INC 31.9%

Value $3.269B Shares 49,064,576 Est. Cost $32.73 Unrealized +65.9%

— CEREVEL THERAPEUTICS HLDNG, INC. 15.2%

Value $1.553B Shares 60,632,356 Est. Cost $16.58 Unrealized —

AVAH AVEANNA HEALTHCARE HLDGS INC 9.8%

Value $1.002B Shares 81,029,675 Est. Cost $11.86 Unrealized 0.0%

IQV IQVIA HLDGS INC 1.5%

Value $150M Shares 617,484 Est. Cost $101.80 Unrealized +126.8%

ADV ADVANTAGE SOLUTIONS INC 0.3%

Value $31.18M Shares 2,890,000 Est. Cost $10.52 Unrealized +17.4%

ATTOF ATENTO S A 0.0%

Value $4.015M Shares 156,574 Est. Cost $20.11 Unrealized +8.4%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	DIVERSEY HLDGS LTD	236,350,134	$4.233B	41.3%	$14.71	—	ORD SHS	G28923103
SGRY	SURGERY PARTNERS INC	49,064,576	$3.269B	31.9%	$32.73	+65.9%	COM	86881A100
—	CEREVEL THERAPEUTICS HLDNG, INC.	60,632,356	$1.553B	15.2%	$16.58	—	COM	15678U128
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,029,675	$1.002B	9.8%	$11.86	0.0%	COM	05356F105
IQV	IQVIA HLDGS INC	617,484	$150M	1.5%	$101.80	+126.8%	COM	46266C105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$31.18M	0.3%	$10.52	+17.4%	COM CL A	00791N102
ATTOF	ATENTO S A	156,574	$4.015M	0.0%	$20.11	+8.4%	SHS	L0427L204